A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseases

Molecular and Cellular Proteomics

Volumn 10, Issue 6, 2011, Pages

  Menon, Krishnakumar N ^a,b   Steer, David L ^a   Short, Martin ^a   Petratos, Steven ^a   Smith, Ian ^a   Bernard, Claude C A ^a  

^a MONASH UNIVERSITY   (Australia)

^b AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CRYSTALLIN; ASPARTATE AMINOTRANSFERASE; BETA CRYSTALLIN; BIOLOGICAL MARKER; BRAIN PROTEIN; COFILIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; CYCLOPHILIN A; ENOLASE; MYELIN; PROTEIN 14 3 3; UBIQUITIN THIOLESTERASE; COLLAPSIN RESPONSE MEDIATOR PROTEIN-2; NERVE PROTEIN; SIGNAL PEPTIDE; UBIQUITIN CARBOXYL TERMINAL HYDROLASE L 1, HUMAN; UBIQUITIN CARBOXYL-TERMINAL HYDROLASE L-1, HUMAN;

ADULT; AGED; ARTICLE; BIOTINYLATION; BRAIN HOMOGENATE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENERGY METABOLISM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MITOCHONDRIAL RESPIRATION; MULTIPLE SCLEROSIS; NERVE FIBER MEMBRANE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; BRAIN; CEREBROSPINAL FLUID; CHEMISTRY; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MYELIN SHEATH; NERVE FIBER; PATHOLOGY; PROTEIN CEREBROSPINAL FLUID LEVEL; WESTERN BLOTTING;

ADULT; AGED; AXONS; BIOTINYLATION; BLOTTING, WESTERN; BRAIN; CEREBROSPINAL FLUID PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENERGY METABOLISM; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE TISSUE PROTEINS; PROTEOMICS; UBIQUITIN THIOLESTERASE;

EID: 79957981423     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M110.000042     Document Type: Article

References (92)

1. Imitola, J., Chitnis, T., and Khoury, S. J. (2006) Insights into the molecular pathogenesis of progression in multiple sclerosis potential implications for future therapies. Arch. Neurol. 63, 25-33 (Pubitemid 43063859)
2. Ferguson, B., Matyszak, M. K., Esiri, M. M., and Perry, V. H. (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120, 393-399
3. Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., and Bö, L. (1998) Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338, 278-285 (Pubitemid 28065253)
4. McFarland, H. F., and Martin, R. (2007) Multiple Sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 8, 913-919
5. Oksenberg, J. R., Panzara, M. A., Begovich, A. B., Mitchell, D., Erlich, H. A., Murray, R. S., Shimonkevitz, R., Sherritt, M., Rothbard, J., Bernard, C. C., and Steinman, L. (1993) Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362, 68-70 (Pubitemid 23087292)
6. Genain, C. P., Cannella, B., Hauser, S. L., and Raine, C. S. (1999) Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5, 170-175 (Pubitemid 29068523)
7. Baranzini, S. E., Jeong, M. C., Butunoi, C., Murray, R. S., Bernard, C. C., and Oksenberg, J. R. (1999) B Cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J. Immunol. 163, 5133-5144
8. Bernard, C. C., Randell, V. B., Horvath, L. B., Carnegie, P. R., and Mackay, I. R. (1981) Antibody to myelin basic protein in extracts of multiple sclerosis brain. Immunology 43, 447-457
9. Salvetti, M., Giovannoni, G., and Aloisi, F. (2009) Epstein-Barr virus and multiple sclerosis. Curr. Opin. Neurol. 22, 201-206
10. Brankin, B., Allen, I. V., Hawkins, S. A., and Wisdom, G. B. (1988) Screening of multiple sclerosis cerebrospinal fluid for autoantibodies. J. Neurol. Sci. 84, 29-40
11. Dumont, D., Noben, J. P., Raus, J., Stinissen, P., and Robben, J. (2004) Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients. Proteomics 4, 2117-2124 (Pubitemid 38880377)
12. Pasinetti, G. M., Ungar, L. H., Lange, D. J., Yemul, S., Deng, H., Yuan, X., Brown, R. H., Cudkowicz, M. E., Newhall, K., Peskind, E., Marcus, S., and Ho, L. (2006) Identification of potential CSF biomarkers in ALS. Neurology 66, 1218-1222 (Pubitemid 43739707)
13. Finehout, E. J., Franck, Z., Choe, L. H., Relkin, N., and Lee, K. H. (2007) Cerebrospinal Fluid Proteomic Biomarkers for Alzheimer's Disease. Ann. Neurol. 61, 120-129
14. Han, M. H., Hwang, S. I., Roy, D. B., Lundgren, D. H., Price, J. V., Ousman, S. S., Fernald, G. H., Gerlitz, B., Robinson, W. H., Baranzini, S. E., Grinnell, B. W., Raine, C. S., Sobel, R. A., Han, D. K., and Steinman, L. (2008) Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 451, 1076-1081 (Pubitemid 351317445)
15. Lovato, L., Cianti, R., Gini, B., Marconi, S., Bianchi, L., Armini, A., Anghileri, E., Locatelli, F., Paoletti, F., Franciotta, D., Bini, L., and Bonetti, B. (2008) Transketolase and 2′,3′-Cyclic-nucleotide 3′-Phosphodiesterase Type I Isoforms Are Specifically Recognized by IgG Autoantibodies in Multiple Sclerosis Patients. Mol. Cell. Proteomics 7, 2337-2349
16. Berger, T., Rubner, P., Schautzer, F., Egg, R., Ulmer, H., Mayringer, I., Dilitz, E., Deisenhammer, F., and Reindl, M. (2003) Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N. Engl. J. Med. 349, 139-145 (Pubitemid 36818783)
17. Robinson, W. H., Fontoura, P., Lee, B. J., de Vegvar, H. E., Tom, J., Pedotti, R., DiGennaro, C. D., Mitchell, D. J., Fong, D., Ho, P. P., Ruiz, P. J., Maverakis, E., Stevens, D. B., Bernard, C. C., Martin, R., Kuchroo, V. K., van Noort, J. M., Genain, C. P., Amor, S., Olsson, T., Utz, P. J., Garren, H., and Steinman, L. (2003) Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat. Biotechnol. 21, 1033-1039 (Pubitemid 37064732)
18. Quintana, F. J., Farez, M. F., Viglietta, V., Iglesias, A. H., Merbl, Y., Izquierdo, G., Lucas, M., Basso, A. S., Khoury, S. J., Lucchinetti, C. F., Cohen, I. R., and Weiner, H. L. (2008) Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 105, 18889-18894
19. Tumani, H., Pfeifle, M., Lehmensiek, V., Rau, D., Mogel, H., Ludolph, A. C., and Brettschneider, J. (2009) Candidate biomarkers of chronic inflammatory demyelination polyneuropathy (CIDP): proteome analysis of cerebrospinal fluid. J. Neuroimmunol. 214, 109-112
20. Ranganathan, S., Williams, E., Ganchev, P., Gopalakrishnan, V., Lacomis, D., Urbinelli, L., Newhall, K., Cudkowicz, M. E., Brown, R. H., Jr., and Bowser, R. (2005) Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J Neurochem. 95, 1461-1471 (Pubitemid 41779269)
21. Winges, K. M., Gilden, D. H., Bennett, J. L., Yu, X., Ritchie, A. M., and Owens, G. P. (2007) Analysis of multiple sclerosis cerebrospinal fluid reveals a continuum of clonally related antibody-secreting cells that are predominantly plasma blasts. J. Neuroimmunol. 192, 226-234
22. von Büdingen, H. C., Harrer, M. D., Kuenzle,. S., Meier, M., and Goebels, N. (2008) Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies. Eur. J. Immunol. 38, 2014-2023
23. Karnezis, T., Mandemakers, W., McQualter, J. L., Zheng, B., Ho, P. P., Jordan, K. A., Murray, B. M., Barres, B., Tessier-Lavigne, M., and Bernard, C. C. (2004) The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat. Neurosci. 7, 736-744
24. Wang, D., Ayers, M. M., Catmull, D. V., Hazelwood, L. J., Bernard, C. C., and Orian, J. M. (2005) Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis. Glia 51, 235-240
25. Sherman, D. L., and Brophy, P. J. (2005) Mechanisms of axon ensheathment and myelin growth. Nat. Rev. Neurosci. 6, 683-690 (Pubitemid 43160317)
26. Susuki, K., and Rasband, M. N. (2008) Molecular mechanisms of node of Ranvier formation. Curr. Opin. Cell Biol. 20, 616-623
27. Goto, K., Kurihara, T., Takahashi, Y., and Kondo, H. (1990) Expression of genes for the myelin-specific proteins in Oligodendrocytes in vivo demands the presences of axons. Neurosci. Lett. 117, 269-274 (Pubitemid 20291615)
28. Peles, E., and Salzer J. L. (2000) Molecular domains of myelinated axons. Curr. Opin. Neurobiol. 10, 558-565
29. Menon, K., Rasband, M. N., Taylor, C. M., Brophy, P., Bansal, R., and Pfeiffer, S. E. (2003) The myelin-axolemmal complex: biochemical dissection and the role of galactosphingolipids. J. Neurochem. 87, 995-1009
30. Segal, P., Teitelbaum, D., and Ohry, A. (1983) Cell-mediated immunity to nervous system antigens in diabetic patients with neuropathy. Isr. J. Med. Sci. 19, 7-10 (Pubitemid 13128158)
31. Ejskjaer, N. T., Zanone, M. M., and Peakman, M. (1998) Autoimmunity in diabetic autonomic neuropathy: does the immune system get on your nerves? Diabet. Med. 15, 723-729 (Pubitemid 28396523)
32. Vinik, A. I., Anandacoomaraswamy, D., and Ullal, J. (2005) Antibodies to neuronal structures: innocent bystanders or neurotoxins? Diabetes Care 28, 2067-2072 (Pubitemid 41060994)
33. Wu, Y., Li, Q., and Chen, X. Z. (2007) Detecting protein-protein interactions by far western blotting. Nat Protoc 2, 3278-3284
34. Azari, M., Ozturk, E., Profyris, C., Wang, S., Small, D., Bernard, C. C .A., and Petratos, S. (2008) LIF treatment reduces Nogo-A deposits in spinal cord injury, modulating Rho GTPase activity and CRMP-2 phosphorilation. J. Neurodegeneration Regeneration 1, 23-29
35. Petratos, S., Gonzales, M. F., Azari, M. F., Marriott, M., Minichiello, R. A., Shipham, K. A., Profyris, C., Nicolaou, A., Boyle, K., Cheema, S. S., and Kilpatrick, T. J. (2004) Expression of the low-affinity neurotrophin receptor, p75(NTR), is upregulated by oligodendroglial progenitors adjacent to the Subventricular zone in response to demyelination. Glia 48, 64-75 (Pubitemid 39390849)
36. Senatorov, V. V., Charles, V., Reddy, P. H., Tagle, D. A., and Chuang, D. M. (2003) Overexpression and nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase in a transgenic mouse model of Huntington's disease. Mol. Cell. Neurosci. 22, 285-297
37. Dhar-Chowdhury, P., Harrell, M. D., Han, S. Y., Jankowska, D., Parachuru, L., Morrissey, A., Srivastava, S., Liu, W., Malester, B., Yoshida, H., and Coetzee, W. A. (2005) The glycolytic enzymes, glyceraldehyde-3-phosphate dehydrogenase, triose-phosphate isomerase, and pyruvate kinase are components of the K(ATP) channel macromolecular complex and regulate its function. J. Biol. Chem. 280, 38464-38470
38. Oláh, J., Orosz, F., Puskás, L. G., Hackler, L., Jr., Horányi, M., Polgár, L., Hollán, S., and Ovádi, J. (2005) Triosephosphate isomerase deficiency: consequences of an inherited mutation at mRNA, protein and metabolic levels. Biochem. J. 392, 675-683
39. Lu, Z. H., Chakraborty, G., Ledeen, R. W., Yahya, D., and Wu, G. (2004) N-Acetylaspartate synthase is bimodally expressed in microsomes and mitochondria of brain. Brain Res. Mol. Brain Res. 122, 71-78 (Pubitemid 38264548)
40. Moffett, J. R., Ross, B., Arun, P., Madhavarao, C. N., and Namboodiri, A. M. (2007) N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog. Neurobiol. 81, 89-131
41. Petratos, S., Azari, M. F., Ozturk, E., Papadopoulos, R., and Bernard, C. C. A. (2010). Novel Therapeutic targets for axonal degeneration in multiple sclerosis. J. Neuropathol. Exp. Neurol. 69, 323-334
42. Vyshkina, T., and Kalman, B. (2008) Autoantibodies and neurodegeneration in multiple sclerosis. Lab. Invest. 88, 796-807
43. Arimura, N., and Kaibuchi, K. (2007) Neuronal polarity: from extracellular signals t o intracellular mechanisms. Nat. Rev. Neurosci. 8, 194-205 (Pubitemid 46294662)
44. Petratos, S., Li, Q. X., George, A. J., Hou, X., Kerr, M. L., Unabia, S. E., Hatzinisiriou, I., Maskel, D., Aguilar, M. I., and Small, D. H. (2008) The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. Brain 131, 90-108
45. Forooghian, F., Adamus, G., Sproule, M., Westall, C., and O'Connor, P. (2007) Enolase autoantibodies and retinal function in multiple sclerosis patients. Graefes Arch. Clin. Exp. Ophthalmol. 245, 1077-1084 (Pubitemid 47034331)
46. Zhu, C., Wang, X., Deinum, J., Huang, Z., Gao, J., Modjtahedi, N., Neagu, M. R., Nilsson, M., Eriksson, P. S., Hagberg, H., Luban, J., Kroemer, G., and Blomgren, K. (2007) Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxiaischemia. J. Exp. Med. 204, 1741-1748 (Pubitemid 47236312)
47. Setsuie, R., and Wada, K. (2007) The functions of UCH-L1 and its relation to neurodegenerative diseases. Neurochem. Int. 51, 105-111 (Pubitemid 47179898)
48. Wilkinson, K. D., Lee, K. M., Deshpande, S., Duerksen-Hughes, P., Boss, J. M., and Pohl, J. (1989) The neuron-specific protein PGP 9.5 is a ubiuitin carboxyl-terminal hydrolase. Science 246, 670-673 (Pubitemid 19283361)
49. Teunissen, C. E., Dijkstra, C., and Polman, C. (2005) Biological markers in CSF and blood for axonal degeneration in multiple sclerosis. Lancet Neurol. 4, 32-41 (Pubitemid 40023234)
50. Sokoloff, L. (1977) Relation between physiological function and energy metabolism in the central nervous system. J. Neurochem. 29, 13-26
51. Kolln, J., Ren, H. M., Da, R. R., Zhang, Y., Spillner, E., Olek, M., Hermanowicz, N., Hilgenberg, L. G., Smith, M. A., van den Noort, S., and Qin, Y. (2006) Triosephosphate isomerase- and glyceraldehyde-3-phosphate dehydrogenase-reactive autoantibodies in the cerebrospinal fluid of patients with multiple sclerosis. J. Immunol. 177, 5652-5658 (Pubitemid 44527641)
52. Terrier, B., Degand, N., Guilpain, P., Servettaz, A., Guillevin, L., and Mouthon, L. (2007) Alpha-enolase: a target of antibodies in infectious and autoimmune diseases. Autoimmun. Rev. 6, 176-182 (Pubitemid 46201958)
53. Jensen, N. A., Pedersen, K. M., Celis, J. E., and West, M. J. (1998) Failure of central nervous system myelination in MBP/c-myc transgenic mice: evidence for c-myc cytotoxicity. Oncogene. 16, 2123-2129 (Pubitemid 28211687)
54. Liss, B., Haeckel, O., Wildmann, J., Miki, T., Seino, S., and Roeper, J. (2005) K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons. Nat. Neurosci. 8, 1742-1751 (Pubitemid 41683203)
55. Laschet, J. J., Minier, F., Kurcewicz, I., Bureau, M. H., Trottier, S., Jeanneteau, F., Griffon, N., Samyn, B., Van Beeumen, J., Louvel, J., Sokoloff, P., and Pumain, R. (2004) Glyceraldehyde-3-phosphate dehydrogenase is a GABAA receptor kinase linking glycolysis to neuronal inhibition. J. Neurosci. 24, 7614-7622 (Pubitemid 39186815)
56. Mazzola, J. L., and Sirover, M. A. (2001) Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts. J. Neurochem. 76, 442-449
57. Mohamed, H. A., Mosier, D. R., Zou, L. L., Siklós, L., Alexianu, M. E., Engelhardt, J. I., Beers, D. R., Le, W. D., and Appel, S. H. (2002) Immunoglobulin Fc gamma receptor promotes immunoglobulin uptake, immunoglobulin-mediated calcium increase, and neurotransmitter release in motor neurons. J. Neurosci. Res. 69, 110-116
58. Yamamoto, T., Iwasaki, Y., Konno, H., Iizuka, H., and Zhao, J. X. (1987) Retrograde transport and differential accumulation of serum proteins in motor neurons: implications for motor neuron diseases. Neurology 37, 843-846
59. Mor, F., Izak, M., and Cohen, I. R. (2005) Identification of aldolase as a target antigen in Alzheimer's disease. J. Immunol. 175, 3439-3445
60. Wang, P., Saraswati, S., Guan, Z., Watkins, C. J., Wurtman, R. J., and Littleton, J. T. (2004) A Drosophila temperature-sensitive seizure mutant in phosphoglycerate kinase disrupts ATP generation and alters synaptic function. J. Neurosci. 24, 4518-4529
61. Mahajan, V. B., Pai, K. S., Lau, A., and Cunningham, D. D. (2000) Creatine kinase, an ATP-generating enzyme, is required for thrombin receptor signaling to the cytoskeleton. Proc. Natl. Acad. Sci. U.S.A. 97, 12062-12067
62. Shavit, E., Beilin, O., Korczyn, A. D., Sylantiev, C., Aronovich, R., Drory, V. E., Gurwitz, D., Horresh, I., Bar-Shavit, R., Peles, E., and Chapman, J. (2008) Thrombin receptor PAR-1 on myelin at the node of Ranvier: a new anatomy and physiology of conduction block. Brain 131, 1113-1122 (Pubitemid 351499419)
63. Dyer, C. A., and Matthieu, J. M. (1994) Antibodies to myelin/oligodendrocyte-specific protein and myelin/oligodendrocyte glycoprotein signal distinct changes in the organization of cultured oligodendroglial membrane sheets. J. Neurochem. 62, 777-787
64. Marta, C. B., Taylor, C. M., Coetzee, T., Kim, T., Winkler, S., Bansal, R., and Pfeiffer, S. E. (2003) Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology. J. Neurosci. 23, 5461-5471
65. Mutsaers, S. E., and Carroll, W. M. (1998) Focal accumulation of intraaxonal mitochondria in demyelination of the cat optic nerve. Acta Neuropathol. (Berl) 96, 139-143
66. Lu, F., Selak, M., O'Connor, J., Croul, S., Lorenzana, C., Butunoi, C., and Kalman, B. (2000) Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J. Neurol. Sci. 177, 95-103
67. Sergeant, N., Wattez, A., Galván-valencia, M., Ghestem, A., David, J. P., Lemoine, J., Sautiére, P. E., Dachary, J., Mazat, J. P., Michalski, J. C., Velours, J., Mena-López, R., and Delacourte, A. (2003) Association of ATP synthase alpha-chain with neurofibrillary degeneration in Alzheimer's disease. Neuroscience 117, 293-303 (Pubitemid 36259745)
68. Yuan, S., Fu, Y., Wang, X., Shi, H., Huang, Y., Song, X., Li, L., Song, N., and Luo, Y. (2008) Voltage-dependent anion channel 1 is involved in endostatin-induced endothelial cell apoptosis. FASEB J. 22, 2809-2820
69. Shoshan-Barmatz, V., and Gincel, D. (2003) The voltage dependent anion channel:characterization, modulation, and role in mitochondrial function in cell life and death. Cell. Biochem. Biophys. 39, 279-292 (Pubitemid 41270796)
70. Zaid, H., Abu-Hamad, S., Israelson, A., Nathan, I., and Shoshan-Barmatz, V. (2005) The voltage dependent anion channel-1 modulates apoptotic cell death. Cell. Death. Differ. 12, 751-760 (Pubitemid 40945982)
71. Butterfield, D. A., Perluigi, M., and Sultana, R. (2006) Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur. J. Pharmacol. 545, 39-50 (Pubitemid 44215876)
72. Ghosh, T., Pandey, N., Maitra, A., Brahmachari, S. K., and Pillai, B. (2007) A role for voltage-dependent anion channel Vdac1 in polyglutamine- mediated neuronal cell death. PLoS One. 2, e1170
73. Siger-Zajdel, M., and Selmaj, K. W. (2005) Proton magnetic resonance spectroscopy of normal appearing white matter in familial and sporadic multiple sclerosis. J. Neurol. 252, 830-832
74. Madhavarao, C. N., Chinopoulos, C., Chandrasekaran, K., and Namboodiri, M. A. (2003) Characterization of the N-acetylaspartate biosynthetic enzyme from rat brain. J. Neurochem. 86, 824-835
75. Krantic, S., Mechawar, N., Reix, S., and Quirion, R. (2005) Molecular basis of programmed cell death involved in neurodegeneration. Trends Neurosci. 28, 670-676 (Pubitemid 41654391)
76. Forte, M., Gold, B. G., Marracci, G., Chaudhary, P., Basso, E., Johnsen, D., Yu, X., Fowlkes, J., Rahder, M., Stem, K., Bernardi, P., and Bourdette, D. (2007) Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 104, 7558-7563 (Pubitemid 47185945)
77. Chen, Y., Tian, D., Ku, L., Osterhout, D. J., and Feng, Y. (2007) The selective RNA-binding protein quaking I (QKI) is necessary and sufficient for promoting oligodendroglia differentiation. J. Biol. Chem. 282, 23553-23560 (Pubitemid 47311955)
78. Aquino, D. A., Peng, D., Lopez, C., and Farooq, M. (1998) The constitutive heat shock protein-70 is required for optimal expression of myelin basic protein during differentiation of oligodendrocytes. Neurochem. Res. 23, 413-420 (Pubitemid 28109888)
79. Lund, B. T., Chakryan, Y., Ashikian, N., Mnatsakanyan, L., Bevan, C. J., Aguilera, R., Gallaher, T., and Jakowec, M. W. (2006) Association of MBP peptides with Hsp70 in normal appearing human white matter. J. Neurol. Sci. 249, 122-134
80. Mycko, M. P., Cwiklinska, H., Walczak, A., Libert, C., Raine, C. S., and Selmaj, K. W. (2008) A heat shock protein gene (Hsp70.1) is critically involved in the generation of the immune response to myelin antigen. Eur. J. Immunol. 38, 1999-2013
81. Goldbaum, O., and Richter-Landsberg, C. (2001) Stress proteins in oligodendrocytes: differential effects of heat shock and oxidative stress. J. Neurochem. 78, 1233-1242 (Pubitemid 32899755)
82. Gurbuxani, S., Schmitt, E., Cande, C., Parcellier, A., Hammann, A., Daugas, E., Kouranti, I., Spahr, C., Pance, A., Kroemer, G., and Garrido, C. (2003) Heat shock protein 70 binding inhibits the nuclear import of apoptosis-inducing factor. Oncogene. 22, 6669-6678 (Pubitemid 37372207)
83. Ricard, D., Rogemond, V., Charrier, E., Aguera, M., Bagnard, D., Belin, M. F., Thomasset, N., and Honnorat, J. (2001) Isolation and expression pattern of human Unc-33-like phosphoprotein 6/collapsing response mediator protein 5 (Ulip6/CRMP5): coexistence with Ulip2/ CRMP2 in Sema3a- sensitive oligodendrocytes. J. Neurosci. 21, 7203-7214 (Pubitemid 32846968)
84. Fukata, Y., Itoh, T. J., Kimura, T., Ménager, C., Nishimura, T., Shiromizu, T., Watanabe, H., Inagaki, N., Iwamatsu, A., Hotani, H., and Kaibuchi, K. (2002) CRMP-2 binds to tubulin Mechanisms of Neuronal Polarization 45 heterodimers to promote microtubule assembly. Nat. Cell Biol. 4, 583-591
85. Inagaki, N., Chihara, K., Arimura, N., Ménager, C., Kawano, Y., Matsuo, N., Nishimura, T., Amano, M., and Kaibuchi, K. (2001) CRMP-2 induces axons in cultured hippocampal neurons. Nat. Neurosci. 4, 781-782 (Pubitemid 32702507)
86. Maloney, M. T., and Bamburg, J. R. (2007) Cofilin-mediated neurodegeneration in Alzheimer's disease and other amyloidopathies. Mol. Neurobiol. 35, 21-44
87. Lees, F., MacDonald, A. M., and Turner, J. W. (1964) Leber's disease with symptoms resembling disseminated sclerosis. J. Neurol. Neurosurg. Psychiatry 27, 415-421
88. Smith, P. R., Cooper, J. M., Govan, G. G., Riordan-Eva, P., Harding, A. E., and Schapira, A. H. (1995) Antibodies to human optic nerve in Leber's hereditary optic neuropathy. J. Neurol. Sci. 130, 134-138
89. Martínez-Yélamos, A., Rovira, A., Sánchez-Valle, R., Martínez-Yélamos, S., Tintoré, M., Blanco, Y., Graus, F., Montalban, X., Arbizu, T., and Saiz, A. (2004) CSF 14-3-3 protein assay and MRI as prognostic markers in patients with a clinically isolated syndrome suggestive of MS. J. Neurol. 251, 1278-1279 (Pubitemid 39517936)
90. Bartosik-Psujek, H., and Archelos, J. J. (2004) Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG. J. Neurol. 251, 414-420 (Pubitemid 38501298)
91. Birkenfeld, J., Betz, H., and Roth, D. (2003) Identification of cofilin and LIM domain-containing protein kinase 1 as novel interaction partners of 14-3-3z. Biochem. J. 369, 45-54 (Pubitemid 36174124)
92. Soosairajah, J., Maiti, S., Wiggan, O., Sarmiere, P., Moussi, N., Sarcevic, B., Sampath, R., Bamburg, J. R., and Bernard, O. (2005) Interplay between components of a novel LIM kinase-slingshot phosphatase complex regulates cofilin. EMBO J. 24, 473-486 (Pubitemid 40343250)